MUSTANG BIO, INC. Current Assets
MUSTANG BIO, INC. (MBIO) had Current Assets of $17.59 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-03-19
- 2025-12-31: Assets, Current $17.59M.
- 2025-09-30: Assets, Current $19.36M.
- 2025-06-30: Assets, Current $13.05M.
- 2025-03-31: Assets, Current $14.91M.
| Period end | Assets, Current |
|---|---|
| 2025-12-31 | $17.59M 10-K · filed 2026-03-19 |
| 2025-09-30 | $19.36M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $13.05M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $14.91M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $8.61M 10-K · filed 2026-03-19 |
| 2024-09-30 | $6.05M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $7.32M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $9.24M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $11.35M 10-K · filed 2025-03-28 |
| 2023-09-30 | $13.59M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $22.58M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $61.13M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $78.85M 10-K · filed 2024-03-11 |
| 2022-09-30 | $94.45M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $109.38M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $124.15M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $111.71M 10-K · filed 2023-03-30 |
| 2021-09-30 | $121.95M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $131.34M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $130.97M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $99.53M 10-K · filed 2022-03-23 |
| 2020-09-30 | $75.63M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $86.27M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $57.70M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $63.06M 10-K · filed 2021-03-24 |
| 2019-09-30 | $74.36M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $83.42M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $41.61M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $35.13M 10-K · filed 2020-03-16 |
| 2018-09-30 | $41.83M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $48.12M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $55.63M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $61.36M 10-K · filed 2019-03-18 |
| 2017-09-30 | $67.75M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $73.84M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $75.03M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $27.50M 10-K · filed 2018-03-29 |
| 2016-09-30 | $11.12M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |